524 related articles for article (PubMed ID: 22652175)
1. A distinct subpopulation within CD133 positive brain tumor cells shares characteristics with endothelial progenitor cells.
Choi SA; Wang KC; Phi JH; Lee JY; Park CK; Park SH; Kim SK
Cancer Lett; 2012 Nov; 324(2):221-30. PubMed ID: 22652175
[TBL] [Abstract][Full Text] [Related]
2. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
[TBL] [Abstract][Full Text] [Related]
3. Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients.
Ahn JB; Rha SY; Shin SJ; Jeung HC; Kim TS; Zhang X; Park KH; Noh SH; Roh JK; Chung HC
Cancer Lett; 2010 Feb; 288(1):124-32. PubMed ID: 19619937
[TBL] [Abstract][Full Text] [Related]
4. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
Rutella S; Bonanno G; Procoli A; Mariotti A; Corallo M; Prisco MG; Eramo A; Napoletano C; Gallo D; Perillo A; Nuti M; Pierelli L; Testa U; Scambia G; Ferrandina G
Clin Cancer Res; 2009 Jul; 15(13):4299-311. PubMed ID: 19509143
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary studies on cell derivation of neovascularization in human glioma and its functional evaluation].
Fei XF; Zhang QB; Dong J; Wang AD; Wang ZM; Huang Q
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):726-31. PubMed ID: 22335902
[TBL] [Abstract][Full Text] [Related]
6. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
7. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
[TBL] [Abstract][Full Text] [Related]
8. Brief report: impaired in vivo neovascularization capacity of endothelial progenitor cells in patients with systemic sclerosis.
Kuwana M; Okazaki Y
Arthritis Rheumatol; 2014 May; 66(5):1300-5. PubMed ID: 24782187
[TBL] [Abstract][Full Text] [Related]
9. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
[TBL] [Abstract][Full Text] [Related]
10. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors.
Timmermans F; Van Hauwermeiren F; De Smedt M; Raedt R; Plasschaert F; De Buyzere ML; Gillebert TC; Plum J; Vandekerckhove B
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1572-9. PubMed ID: 17495235
[TBL] [Abstract][Full Text] [Related]
11. Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma.
Sun XT; Yuan XW; Zhu HT; Deng ZM; Yu DC; Zhou X; Ding YT
World J Gastroenterol; 2012 Sep; 18(35):4925-33. PubMed ID: 23002366
[TBL] [Abstract][Full Text] [Related]
12. CD133 is essential for glioblastoma stem cell maintenance.
Brescia P; Ortensi B; Fornasari L; Levi D; Broggi G; Pelicci G
Stem Cells; 2013 May; 31(5):857-69. PubMed ID: 23307586
[TBL] [Abstract][Full Text] [Related]
13. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis.
Pallini R; Ricci-Vitiani L; Montano N; Mollinari C; Biffoni M; Cenci T; Pierconti F; Martini M; De Maria R; Larocca LM
Cancer; 2011 Jan; 117(1):162-74. PubMed ID: 20806346
[TBL] [Abstract][Full Text] [Related]
14. Circulating CD34+ progenitor cells modulate host angiogenesis and inflammation in vivo.
Popa ER; Harmsen MC; Tio RA; van der Strate BW; Brouwer LA; Schipper M; Koerts J; De Jongste MJ; Hazenberg A; Hendriks M; van Luyn MJ
J Mol Cell Cardiol; 2006 Jul; 41(1):86-96. PubMed ID: 16780869
[TBL] [Abstract][Full Text] [Related]
15. Endothelial progenitor cells derived from CD34+ cells form cooperative vascular networks.
Guo S; Cheng Y; Ma Y; Yang X
Cell Physiol Biochem; 2010; 26(4-5):679-88. PubMed ID: 21063105
[TBL] [Abstract][Full Text] [Related]
16. Putative CD133+ melanoma cancer stem cells induce initial angiogenesis in vivo.
Zimmerer RM; Matthiesen P; Kreher F; Kampmann A; Spalthoff S; Jehn P; Bittermann G; Gellrich NC; Tavassol F
Microvasc Res; 2016 Mar; 104():46-54. PubMed ID: 26656667
[TBL] [Abstract][Full Text] [Related]
17. Surrogate markers predict angiogenic potential and survival in patients with glioblastoma multiforme.
Greenfield JP; Jin DK; Young LM; Christos PJ; Abrey L; Rafii S; Gutin PH
Neurosurgery; 2009 May; 64(5):819-26; discussion 826-7. PubMed ID: 19404145
[TBL] [Abstract][Full Text] [Related]
18. Are purified or expanded cord blood-derived CD133+ cells better at improving cardiac function?
Senegaglia AC; Barboza LA; Dallagiovanna B; Aita CA; Hansen P; Rebelatto CL; Aguiar AM; Miyague NI; Shigunov P; Barchiki F; Correa A; Olandoski M; Krieger MA; Brofman PR
Exp Biol Med (Maywood); 2010 Jan; 235(1):119-29. PubMed ID: 20404026
[TBL] [Abstract][Full Text] [Related]
19. CD34/CD133 enriched bone marrow progenitor cells promote neovascularization of tissue engineered constructs in vivo.
Herrmann M; Binder A; Menzel U; Zeiter S; Alini M; Verrier S
Stem Cell Res; 2014 Nov; 13(3 Pt A):465-77. PubMed ID: 25460607
[TBL] [Abstract][Full Text] [Related]
20. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
Beier D; Hau P; Proescholdt M; Lohmeier A; Wischhusen J; Oefner PJ; Aigner L; Brawanski A; Bogdahn U; Beier CP
Cancer Res; 2007 May; 67(9):4010-5. PubMed ID: 17483311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
